16 hours AMD is going head-to-head with Nvidia in AI-backed drug discovery with new deal MarketWatch

Chip maker AMD is investing $20 million in AI drug startup Absci, which will use AMD chips and software for drug development.

AI · AMD (AMD) · Investing · NVIDIA (NVDA) · Software · Tech